Skip to main content
Clinical Trials/NCT03183037
NCT03183037CompletedNot Applicable

Acupuncture for Persistent Chemotherapy-induced Peripheral Neuropathy Symptoms in Solid Tumor Survivors: A Pilot Study

Memorial Sloan Kettering Cancer Center2 sites in 1 country75 target enrollmentStarted: June 7, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
75
Locations
2
Primary Endpoint
change in the proportion of patients with a CIPN severity

Study Overview

Brief Summary

The purpose of this study is to compare the effects of real acupuncture with placebo acupuncture or usual care on symptoms of nerve damage from chemotherapy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •English-speaking
  • •Age ≥ 18 years old
  • •Solid tumor survivors with no evidence of disease
  • •Moderate to severe CIPN, defined by symptoms such as numbness, tingling, or pain ratings of 4 or greater on a 0-10 numeric rating scale (NRS)
  • •Have completed neurotoxic chemotherapy at least 3 months prior to enrollment
  • •If taking anti-neuropathy medications, they are on a stable regimen (no change in 3 months)

Exclusion Criteria

  • •Patients with a pacemaker
  • •Prior acupuncture treatment within 5 years of enrollment

Arms & Interventions

Acupuncture Treatment Group

Experimental

Ten acupuncture treatments over the course of eight weeks, with twice weekly acupuncture treatments for the first two weeks, and then weekly treatment thereafter.

Intervention: Acupuncture (Procedure)

Acupuncture Treatment Group

Experimental

Ten acupuncture treatments over the course of eight weeks, with twice weekly acupuncture treatments for the first two weeks, and then weekly treatment thereafter.

Intervention: questionnaires (Behavioral)

Sham Acupuncture Treatment Group

Placebo Comparator

Ten sham acupuncture treatments over the course of eight weeks, with twice weekly sham acupuncture treatments for the first two weeks, and then weekly sham acupuncture treatment thereafter.

Intervention: Sham Acupuncture (Procedure)

Sham Acupuncture Treatment Group

Placebo Comparator

Ten sham acupuncture treatments over the course of eight weeks, with twice weekly sham acupuncture treatments for the first two weeks, and then weekly sham acupuncture treatment thereafter.

Intervention: questionnaires (Behavioral)

Usual Care Group

Active Comparator

Twelve weeks of usual care.

Intervention: Usual Care Group (Other)

Usual Care Group

Active Comparator

Twelve weeks of usual care.

Intervention: questionnaires (Behavioral)

Outcomes

Primary Outcomes

change in the proportion of patients with a CIPN severity

Time Frame: up to 12 weeks

according to the NCI-CTC 4.0

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials